Wednesday, February 27, 2019

Lupin launches chronic angina treatment drug in the US

Lupin launches chronic angina treatment drug in the US The newly launched product, in strengths of 500 mg and 1,000 mg, is a generic version of Gilead Sciences#39; Ranexa ER tablets.

from Moneycontrol Business News https://ift.tt/2VsUBml

No comments:

Post a Comment

GMR Airports shares rise 3% as company swings to black with Rs 202 crore profit in Q3

GMR Airports share price: GMR Airports shares gained 3% on news of significant profit for Q3 FY25, driven by increased passenger traffic and...